A GLOBAL LEADER IN DIGITAL HEALTH
About DarioHealth
DarioHealth Corp. (NASDAQ:DRIO) s a leader in the global digital health market, revolutionizing how people with chronic conditions manage and improve their health through behavior change between doctor visits. Dario offers a hyper-personalized whole-person solution covering multiple conditions including diabetes, hypertension, weight management, musculoskeletal, and behavioral health, within one integrated, Al-powered technology platform. With over 100 peer-reviewed scientific studies, Dario offers measurable clinical improvement and a value-based pricing model with an attractive ROI of up to 5x for payers including employers and insurers. Dario’s blue-chip customer base spans over 160 clients including Fortune 100 employers and national health plans. As payers are increasingly focused on containing rising healthcare costs while supporting healthy lives, the digital health industry is delivering valuable solutions and showing clear signs of momentum in the capital markets.
Our Mission
Dario is on a mission to drive the behavior change that powers better health.
Dario was an early entrant into the digital health space, pioneering direct-to-consumer diabetes management, building unparalleled expertise and amassing large data sets which are now used to drive its Al-powered technology platform and deliver multi-condition digital health solutions. In 2025 Dario leveraged its position and platform, pivoting to a highly sustainable, high margin B2B2C recurring revenue business focused on delivering a multi-condition solution to Tier-1 employers and insurers.
Dario reported sequential revenue growth in Q4 2025 and gross margins of 57% for the full 2025 year and two consecutive years of 80% non-GAAP gross margins on its B2B2C business. The 2025 sales season was Dario's strongest on record, generating $12.9 million in contracted and late stage, annual recurring revenue, set to contribute revenue in 2026 and 2027. The Company's pipeline of commercial opportunities grew to $122 million as of the end of 2025 based on 200+ opportunities that are B2B2C. Dario continues to reduce its operating expenses and is expecting to reach cash flow break even by mid-2027.
The top priority of customers is savings and Dario is delivering. Dario’s customers are realizing up to a 5-fold ROI, with an average annual medical cost savings of $5,077 per Dario user. A key competitive advantage is Dario's multi-condition platform covering 6+ conditions, more than any other digital health company on the market today.
The treatment of chronic diseases and mental health conditions in the U.S. alone accounts for 90% of the nation's $4.9 trillion in healthcare expenditures, $250 billion of which is Dario's serviceable addressable market. Dario's Al-driven digital healthcare platform effectively engages patients with user-friendly digital tools along with personal coaching, leading to quantified improved outcomes.
Dario brings one of the most comprehensive, clinically proven unified product offerings to the digital health space with a well established track record. An unmatched 100+ studies published in influential medical journals and presented at scientific conferences, including 9 conducted by Dario’s customer, Sanofi, demonstrate improved health outcomes and reduced spending.
Dario has dozens of patents relating to its platform technology and Al coaching that compliments human coaching to optimize health. As an early entrant into the market, Dario has trained its Al on a cumulative 250,000 users and 13 billion user data points to both build clinical services and support users in the care pathway. This data set coupled with proprietary IP, and Al holds unique and substantial value for the Company.
